% Relative Effect | NbES | NbAC | d | D |
---|---|---|---|---|
MOX versus before injection | −83** | −33* | +65** | −35* |
(15 min) | (75 min) | (55 min) | (15 min) | |
MOX versus saline | −81* | −35 | +81*** | −31* |
(15 min) | (15 min) | (55 min) | (55 min) | |
PRO versus before injection | −98** | −79** | +188 | −58** |
(35 min) | (35 min) | (55 min) | (35 min) | |
PRO versus saline | −96** | −81* | +155 | −55* |
(35 min) | (15 min) | (55 min) | (35 min) | |
PRO versus MOX | −92* | −74* | +72 | −39 |
(140 min) | (55 min) | (35 min) | (35 min) |
Data are expressed in percentage of variation (%). Numbers in parentheses indicate the kinetic of maximal antiarrhythmic effects (time after i.v. injection of drug).
d, delay of arrhythmias onset after the start of stimulation; D, total duration of arrhythmias for each stimulation.
*P < .05; ** P < .01; ***P < .001 (Contrast method comparison).